CSAM Test Bank Questions

CSAM Test Bank Questions Primary & Secondary syphilis cases in the U.S. have surged reaching a 20-year record high & cases of congenital syphilis have more than doubled in the past 4 years. All the following are true about syphilis EXCEPT: A. Neonatal symptoms of congenital syphilis include deformed bones, severe anemia, hepatosplenomegaly, neurological problems, meningitis, & skin rashes. B. Screening for syphilis requires use of a nontreponemal test (e.g. VDRL or RPR) or a treponemal test (e.g. EIA, FTA-ABS, TPPA, or MHA-TP), but not both. C. Up to 40% of pregnancies with untreated syphilis will result in miscarriage, stillbirth, or early infant death. D. Known risk factors for syphilis include: multiple sex partners, substance use disorders, poverty, exchanging sex for drugs, money, or housing, & a history of incarceration. Next B BOTH a nontreponemal test AND a treponemal test are required. The treponemal test will be positive in patients with current or past infection. The nontreponemal test may be positive for conditions other than syphilis; when syphilis is present, this test will differentiate current infection needing treatment from prior, treated infection. Patients with SUDs are in a high-risk group for syphilis. Screening for syphilis is a required part of admission to opioid treatment programs. Repeated testing is recommended for pregnant woman at increased risk. Up to 40% of pregnancies with untreated syphilis result in miscarriage, stillbirth, or early infant death. Potential symptoms of congenital syphilis include deformed bones, severe anemia, hepatosplenomegaly, jaundice, neurological problems, meningitis, & skin rashes. Usually, symptoms emerge within the first few weeks of life, but baby may be asymptomatic only to have symptoms occur years later, causing serious problems (such as those listed above), developmental delay, seizures, or death. The global pooled syphilis prevalence amongst men having sex with men has risen to unacceptable levels and was estimated at 7.5% (95% CI 7·0–8·0, 345